title: Effects of the compounds MV8608 and MV8612 obtained from Mandevilla velutina in the model of hemorrhagic cystitis induced by cyclophosphamide in rats.
abstract: Hemorrhagic cystitis (HC) is a common side effect observed in patients under chemotherapy with cyclophosphamide (CYP). The urotoxic side effects of CYP are attributed to the metabolic compound acrolein, and can be partially prevented by the uroprotector agent 2-mercaptoethene sulfate (Mesna). The present study analyzed the anti-inflammatory and the antinociceptive effects of compounds MV8608 and MV8612 obtained from Mandevilla velutina in the rat model of CYP-induced HC. Male Wistar rats were used (six to eight per group, 220-250 g). HC was induced by a single administration of CYP (100 mg/kg, ip). Three behavioral parameters--breathing rate, closing of the eyes, and specific posture--were used as nociception indexes, and scored at different time intervals (15-180 min) after cystitis induction. As inflammatory parameters, hemorrhage presence, edema formation, and bladder weight were determined at 24 h after CYP administration. The neutrophil migration was assessed by means of myeloperoxidase (MPO activity), 4 h after cystitis induction. As expected, Mesna treatment was able to reduce in a significant manner all the inflammatory and the nociceptive parameters induced by CYP. Of note, the administration of MV8608 significantly inhibited the hemorrhage formation and the neutrophil recruitment, while the MV8612 treatment markedly reduced the bladder weight, without interfering with neutrophil influx. Interestingly, the treatment with either MV8608 or MV8612 markedly reduced the nociceptive responses. The present results clearly indicate that MV8608 and MV8612 might represent important alternatives to prevent side effects, especially the nociception, following chemotherapy with CYP.
authors.affiliation: Programa de Pós-Graduação em Biologia Celular e Molecular, PUCRS, Porto Alegre, Rio Grande do Sul, Brazil.
authors.forename: André A
authors.initials: AA
authors.lastname: Santos
authors.forename: Paulo C
authors.initials: PC
authors.lastname: Leal
authors.forename: Maria I A
authors.initials: MI
authors.lastname: Edelweiss
authors.forename: Tiago Giuliani
authors.initials: TG
authors.lastname: Lopes
authors.forename: João B
authors.initials: JB
authors.lastname: Calixto
authors.forename: Fernanda B
authors.initials: FB
authors.lastname: Morrone
authors.forename: Maria M
authors.initials: MM
authors.lastname: Campos
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D029062:Apocynaceae / Q000737:chemistry*; D003520:Cyclophosphamide / Q000009:adverse effects*; D003556:Cystitis / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D004195:Disease Models, Animal; D006027:Glycosides / Q000494:pharmacology / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D008297:Male; D015080:Mesna / Q000627:therapeutic use; D009929:Organ Size / Q000187:drug effects; D010147:Pain Measurement; D009195:Peroxidase / Q000378:metabolism; D020011:Protective Agents / Q000627:therapeutic use; D051381:Rats; D017208:Rats, Wistar; D013256:Steroids / Q000494:pharmacology / Q000627:therapeutic use*; D001743:Urinary Bladder / Q000187:drug effects / Q000201:enzymology / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D018906:Antineoplastic Agents, Alkylating; D006027:Glycosides; D020011:Protective Agents; D013256:Steroids; C085133:MV 8608; C085132:MV 8612; D003520:Cyclophosphamide; D009195:Peroxidase; D015080:Mesna
references.citation: J Urol. 1997 May;157(5):1946-50
references.pmid: 9112569
references.citation: J Urol. 1992 Oct;148(4):1326-30
references.pmid: 1404668
references.citation: Exp Biol Med (Maywood). 2007 Apr;232(4):565-70
references.pmid: 17392493
references.citation: Braz J Med Biol Res. 1999 Oct;32(10):1211-5
references.pmid: 10510257
references.citation: Exp Brain Res. 1995;105(2):220-32
references.pmid: 7498375
references.citation: Pediatr Blood Cancer. 2007 Sep;49(3):341-3
references.pmid: 16333822
references.citation: Br J Pharmacol. 1985 Aug;85(4):729-31
references.pmid: 4041675
references.citation: J Urol. 1993 Apr;149(4):719-23
references.pmid: 8455230
references.citation: BJU Int. 2009 Jan;103(2):264-9
references.pmid: 18710439
references.citation: J Urol. 2001 Sep;166(3):1119-23
references.pmid: 11490309
references.citation: Agents Actions. 1992 Jul;36(3-4):222-9
references.pmid: 1382376
references.citation: Urology. 2006 Mar;67(3):636-41
references.pmid: 16527596
references.citation: Cell Biol Toxicol. 2007 Sep;23(5):303-12
references.pmid: 17225077
references.citation: Agents Actions. 1991 Jul;33(3-4):272-8
references.pmid: 1719783
references.citation: J Urol. 1984 Sep;132(3):580-2
references.pmid: 6433044
references.citation: Eur J Pharmacol. 1993 Oct 26;243(3):213-9
references.pmid: 8276072
references.citation: Prostaglandins. 1991 May;41(5):515-26
references.pmid: 1907393
references.citation: J Immunol. 2004 Feb 1;172(3):1839-47
references.pmid: 14734768
references.citation: Regul Pept. 2006 Sep 11;136(1-3):98-104
references.pmid: 16764951
references.citation: Brain Res. 2003 Jan 31;961(2):269-76
references.pmid: 12531494
references.citation: J Urol. 2000 Jul;164(1):203-8
references.pmid: 10840460
references.citation: BJU Int. 2007 Dec;100(6):1402-8
references.pmid: 17979934
references.citation: Gynecol Oncol. 2000 Feb;76(2):223-5
references.pmid: 10637075
references.citation: J Urol. 2007 Apr;177(4):1531-6
references.pmid: 17382773
references.citation: J Urol. 1986 Aug;136(2):497-500
references.pmid: 3090278
references.citation: Br J Urol. 1996 Oct;78(4):530-3
references.pmid: 8944508
references.citation: Urology. 2006 Feb;67(2):435-9
references.pmid: 16461118
references.citation: J Urol. 2005 May;173(5):1793-6
references.pmid: 15821589
references.citation: Arch Toxicol. 2005 Aug;79(8):461-5
references.pmid: 15800758
references.citation: J Urol. 1999 Jun;161(6):1988-93
references.pmid: 10332487